Kostas Kaloulis

Kostas Kaloulis currently serves as Chief Executive Officer and Board member at EpiCure Biotechnologies and has held the position of Venture Partner at +ND Capital since September 2018. Kaloulis is a member of the Business Council at Dana-Farber Innovations, contributing to the Dana-Farber Cancer Institute. Additionally, Kaloulis co-founded Avrion Therapeutics, a gene therapy company focused on treating severe neurodegenerative diseases, and serves as Chief Executive Officer and Board member at EVIR Therapeutics, which is developing novel CAR Dendritic cell technology for cancer treatment. Kaloulis co-founded ReMedys, a not-for-profit healthcare organization, and previously served as Chief Executive Officer and co-founder of Arctos Medical, a gene therapy company acquired by Novartis. Kaloulis has held expert roles at Innosuisse, the Swiss Confederation Innovation Agency, and has significant experience in business development with Merck Serono and LifeCare Partners.